Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach

Logsdon, B.; Perumal, T. M.; Swarup, V.; Wang, M.; Funk, C.; Gaiteri, C.; Allen, M.; Wang, X.; Dammer, E.; Srivastava, G.; Mukherjee, S.; Sieberts, S. K.; Omberg, L.; Dang, K. D.; Eddy, J. A.; Snyder, P.; Chae, Y.; Amberkar, S.; Wei, W.; Hide, W.; Preuss, C.; Ergun, A.; Ebert, P. J.; Airey, D. C.; Carter, G. W.; Mostafavi, S.; Yu, L.; Klein, H.-U.; Collier, D. A.; Golde, T.; Levey, A.; Bennett, D. A.; Estrada, K.; Decker, M.; Liu, Z.; Shulman, J. M.; Zhang, B.; Schadt, E.; De Jager, P. L.; Price, N. D.; Ertekin-Taner, N.; Mangravite, L. M.

doi:10.1101/510420

Home/Archive/bioRxiv

bioRxiv · 10.1101/510420

Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach

View original source ↗Export metadata ↓

Abstract

Alzheimers disease (AD) is a complex and heterogenous brain disease that affects multiple inter-related biological processes. This complexity contributes, in part, to existing difficulties in the identification of successful disease-modifying therapeutic strategies. To address this, systems approaches are being used to characterize AD-related disruption in molecular state. To evaluate the consistency across these molecular models, a consensus atlas of the human brain transcriptome was developed through coexpression meta-analysis across the AMP-AD consortium. Consensus analysis was performed across five coexpression methods used to analyze RNA-seq data collected from 2114 samples across 7 brain regions and 3 research studies. From this analysis, five consensus clusters were identified that described the major sources of AD-related alterations in transcriptional state that were consistent across studies, methods, and samples. AD genetic associations, previously studied AD-related biological processes, and AD targets under active investigation were enriched in only three of these five clusters. The remaining two clusters demonstrated strong heterogeneity between males and females in AD-related expression that was consistently observed across studies. AD transcriptional modules identified by systems analysis of individual AMP-AD teams were all represented in one of these five consensus clusters except ROS/MAP-identified Module 109, which was specific for genes that showed the strongest association with changes in AD-related gene expression across consensus clusters. The other two AMP-AD transcriptional analyses reported modules that were enriched in one of the two sex-specific Consensus Clusters. The fifth cluster has not been previously identified and was enriched for genes related to proteostasis. This study provides an atlas to map across biological inquiries of AD with the goal of supporting an expansion in AD target discovery efforts.

Explore related subjects

systems biology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Logsdon, B., Perumal, T. M., Swarup, V., Wang, M., Funk, C., Gaiteri, C., Allen, M., Wang, X., Dammer, E., Srivastava, G., Mukherjee, S., Sieberts, S. K., Omberg, L., Dang, K. D., Eddy, J. A., Snyder, P., Chae, Y., Amberkar, S., Wei, W., Hide, W., Preuss, C., Ergun, A., Ebert, P. J., Airey, D. C., Carter, G. W., Mostafavi, S., Yu, L., Klein, H.-U., Collier, D. A., Golde, T., Levey, A., Bennett, D. A., Estrada, K., Decker, M., Liu, Z., Shulman, J. M., Zhang, B., Schadt, E., De Jager, P. L., Price, N. D., Ertekin-Taner, N., Mangravite, L. M.. 2019-01-03. Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach. https://doi.org/10.1101/510420

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Gene regulatory architecture in antibiotic resistance is optimized for specific dynamic regimens

Cellular responses to antibiotics face a fundamental trade-off: resistance must be deployed quickly enough to prevent the accumulation of drug inside the cell, but expression of resistance genes is costly in the absence of the drug. Therefore, antibiotic responses are typically regulated, controlling not only whether resistance is expressed, but also when, how strongly, and for how long. These regulatory strategies are implemented through the strength and arrangement of promoters and operators. However, it is still not clear how the dynamics of drug exposure select for specific regulatory strategies. Here, we develop a dynamical model of a typical antibiotic response, where a transcriptional repressor senses the drug and regulates expression of a resistance protein, coupled to the effects of the drug on cell growth and gene expression. We define a cost function that weighs the different burdens imposed on the cell over the course of the response, and perform in silico optimization of the regulatory parameters under different selective pressures for three architectures of increasing complexity: constitutive expression of resistance, repression by a constitutively expressed repressor, and repression by a self-regulated repressor. We find that strong drug exposures favor constitutive expression of resistance, high costs of basal expression favor repression by a constitutive repressor, and self-regulation of the repressor is favored only when the response must provide protection while also restraining overexpression of resistance. Stochastic simulations further show that self-regulation of the repressor protects cells against fluctuations in repressor levels, which cause unnecessary induction of resistance before exposure and failed induction after exposure. This framework links the dynamics of the environment to the evolution of gene regulation, providing a basis to predict which regulatory strategies are expected to arise under specific selective pressures.

systems biology↗

bioRxiv2026

Photographic age gap is associated with frailty and predicts survival in laboratory mice

Ageing studies in mice need biomarkers that are cheap, non-invasive and repeatable. We asked how much of a mouse's age can be read from an ordinary photograph, and whether the part that cannot be explained by age carries biological information. We assembled 2,846 photographs of 1,292 mice (four strains, 1 to 34 months old) from seven facilities and predicted age with a frozen self-supervised vision model (DINOv2) and a ridge regression, always tested on facilities the model had never seen. Absolute age transferred poorly between facilities (median absolute error 138 days), because each facility's photographs carried an offset. Relative age transferred well: among mice photographed in the same session, the older mouse was predicted older in 65% of pairs, rising above 95% for age differences over 500 days, and the later photograph of the same mouse was predicted older in 63% of repeat pairs. Sex, in comparison, was inferred more reliably (87%). Mice predicted older than their age were frailer (+0.12 SD per 100 days) and had shorter survival (hazard ratio 1.14 per 100 days), and fourth generation (G4) telomerase-deficient mice looked 151 days older than their wild-type controls. Routine photographs therefore carry a real biological age signal that can be read at no extra cost, best used to compare mice photographed together.

systems biology↗

bioRxiv2026

Intestinal molecular siphoning by engineered bacterial spores for non-systemic treatment of nicotine addiction

Eradicating toxic small molecules from the body typically requires the administrations of therapeutic agents for systemic circulation and tissue distribution, resulting in inevitable adverse events from off-target effects. Here, we propose a intestinal molecular siphoning approach for treating diseases caused by toxic substances, in which enzymatic degradation of a toxic substance in the intestinal lumen serves as a driving force for the diffusion of the toxic substance from blood to gut, and continuous elimination of the toxic substance in the gut could effectively ease substance dependence. Using nicotine as a model substance, a live bacterial system was constructed by displaying a trypsin-resistant nicotine oxidase on the surface of Bacillus subtilis spores, and encapsulating in enteric-coated microspheres for gastric protection and targeted intestinal release. After oral treatments with the live bacterial system in mice, peak concentrations of nicotine in blood and brain were remarkably reduced compared to controls. Moreover, the live bacterial system could effectively attenuate nicotine addiction by suppressing dopamine reward surges to reverse withdrawal hyperalgesia, preventing the upregulation of nicotinic acetylcholine receptors, and alleviating anxiety-like behaviors. These findings show the potential of intestinal molecular siphoning as a target-independent therapeutic strategy for lowering circulating toxic substances through non-systemic enzyme reprogramming.

systems biology↗